NasdaqGM:DRAD

Stock Analysis Report

Executive Summary

Digirad Corporation provides healthcare solutions in the United States and internationally.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Risks

  • Digirad has significant price volatility in the past 3 months.
  • Digirad is not covered by any analysts.

Share Price & News

How has Digirad's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-8.3%

DRAD

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

-65.5%

DRAD

-9.0%

US Healthcare

1.1%

US Market

DRAD underperformed the Healthcare industry which returned -9.4% over the past year.

DRAD underperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

DRADIndustryMarket
7 Day-8.3%0.008%-0.2%
30 Day10.4%-0.8%2.5%
90 Day-25.3%-1.5%1.6%
1 Year-65.5%-65.5%-7.6%-9.0%3.4%1.1%
3 Year-87.9%-89.6%29.6%24.4%45.2%35.8%
5 Year-83.3%-86.8%66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Digirad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Digirad undervalued based on future cash flows and its price relative to the stock market?

0.46x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Digirad to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Digirad to establish if it is available at substantial discount.


Price Based on Earnings

Digirad is loss making, we can't compare its value to the US Healthcare industry average.

Digirad is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Digirad, we can't assess if its growth is good value.


Price Based on Value of Assets

Digirad is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Digirad expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Digirad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Digirad performed over the past 5 years?

-47.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Digirad does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Digirad's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Digirad's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Digirad has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Digirad has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Digirad improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Digirad's financial position?


Financial Position Analysis

Digirad is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Digirad's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Digirad's level of debt (66%) compared to net worth is high (greater than 40%).

Unable to establish if Digirad's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Digirad has sufficient cash runway for 2.9 years based on current free cash flow.

Digirad has less than a year of cash runway if free cash flow continues to grow at historical rates of 42.4% each year.


Next Steps

Dividend

What is Digirad's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Digirad's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Digirad's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Digirad has not reported any payouts.

Unable to verify if Digirad's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Digirad has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Digirad's salary, the management and board of directors tenure and is there insider trading?

3.7yrs

Average management tenure


CEO

Matt Molchan (52yo)

6.2yrs

Tenure

US$637,997

Compensation

Mr. Matthew Gabel Molchan, also known as Matt, has been the Chief Executive Officer and Director of Digirad Corporation since July 01, 2013 and has been its President from February 2013. Mr. Molchan served ...


CEO Compensation Analysis

Matt's remuneration is about average for companies of similar size in United States of America.

Matt's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

3.7yrs

Average Tenure

52yo

Average Age

The tenure for the Digirad management team is about average.


Board Age and Tenure

6.4yrs

Average Tenure

50yo

Average Age

The tenure for the Digirad board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$19,20020 May 19
David Noble
EntityIndividual
Role
Chief Financial Officer
CFO & COO
Shares3,000
Max PriceUS$6.40
BuyUS$5,55017 May 19
David Noble
EntityIndividual
Role
Chief Financial Officer
CFO & COO
Shares853.8
Max PriceUS$6.50
BuyUS$28,38017 May 19
Mitchell Quain
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,800
Max PriceUS$7.50
BuyUS$27,20017 May 19
Jeffrey Eberwein
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares4,000
Max PriceUS$7.30
BuyUS$46,92015 May 19
Mitchell Quain
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares6,900
Max PriceUS$6.80
BuyUS$6,68015 May 19
Jeffrey Eberwein
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares1,000
Max PriceUS$7.10
BuyUS$178,60009 May 19
Jeffrey Eberwein
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares26,000
Max PriceUS$7.00
BuyUS$12,99419 Mar 19
Michael Cunnion
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,624.2
Max PriceUS$8.00
BuyUS$74,33019 Mar 19
Mitchell Quain
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares9,780.3
Max PriceUS$7.60
BuyUS$17,00019 Mar 19
Matthew Molchan
EntityIndividual
Role
Chief Executive Officer
President
Shares2,000
Max PriceUS$8.50
BuyUS$4,92019 Mar 19
John Climaco
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares600
Max PriceUS$8.20
BuyUS$32,80018 Mar 19
David Noble
EntityIndividual
Role
Chief Financial Officer
CFO & COO
Shares4,000
Max PriceUS$8.20
BuyUS$11,10015 Mar 19
Jeffrey Eberwein
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares1,500
Max PriceUS$7.40
BuyUS$16,66216 Nov 18
David Noble
EntityIndividual
Role
Chief Financial Officer
CFO & COO
Shares1,584.2
Max PriceUS$10.60
BuyUS$28,75013 Nov 18
Jeffrey Eberwein
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares2,500
Max PriceUS$11.50

Ownership Breakdown


Management Team

  • Matt Molchan (52yo)

    President

    • Tenure: 6.2yrs
    • Compensation: US$638.00k
  • Martin Shirley (57yo)

    President of Digirad Imaging Solutions

    • Tenure: 3.7yrs
    • Compensation: US$321.37k
  • Bob Halbert

    Senior Director of Human Resource

    • Tenure: 0yrs
  • David Noble (49yo)

    CFO & COO

    • Tenure: 0.7yrs
  • Hannah Bible

    Vice President of Legal

    • Tenure: 0yrs

Board Members

  • Mitch Quain (67yo)

    Independent Director

    • Tenure: 0.7yrs
  • John Sayward (67yo)

    Independent Director

    • Tenure: 11.5yrs
    • Compensation: US$78.50k
  • Matt Molchan (52yo)

    President

    • Tenure: 6.2yrs
    • Compensation: US$638.00k
  • Mike Cunnion (48yo)

    Independent Director

    • Tenure: 5.7yrs
    • Compensation: US$72.13k
  • John Climaco (50yo)

    Independent Director

    • Tenure: 6.8yrs
    • Compensation: US$68.13k
  • Mickey King

    Executive Chairman of Digirad Imaging Solutions

    • Tenure: 7.7yrs
  • Jeff Eberwein (49yo)

    Independent Chairman

    • Tenure: 6.6yrs
    • Compensation: US$75.00k
  • Dimitrios Angelis (49yo)

    Independent Director

    • Tenure: 4.2yrs
    • Compensation: US$72.13k

Company Information

Digirad Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Digirad Corporation
  • Ticker: DRAD
  • Exchange: NasdaqGM
  • Founded: 1985
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$10.580m
  • Shares outstanding: 2.04m
  • Website: https://www.digirad.com

Number of Employees


Location

  • Digirad Corporation
  • 1048 Industrial Court
  • Suite E
  • Suwanee
  • Georgia
  • 30024
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DRADNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJun 2004
FDV1DB (Deutsche Boerse AG)YesCommon StockDEEURJun 2004
DRAD.PNasdaqGM (Nasdaq Global Market)CUM PFD SR AUSUSDSep 2019

Biography

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnosti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:31
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.